Company intelligence / Profile preview

CardiAMP

Sunnyvale, California, United States
Ownership
Private
Employees
~25
Development stage
Other
01

Overview

BioCardia is a clinical-stage regenerative medicine company focused on developing cellular and cell-derived therapeutics for cardiovascular and pulmonary diseases. The company's lead platform, CardiAMP, is an autologous cell therapy system that uses a patient's own bone marrow cells to treat ischemic heart failure and chronic myocardial ischemia. BioCardia's approach integrates a proprietary molecular diagnostic for patient selection, a point-of-care cell processing platform, and the Helix transendocardial delivery system. The company is also developing CardiALLO, an allogeneic cell therapy, and partners with other firms to provide its specialized delivery technologies for various biologic therapies.

Therapeutic areas
CardiovascularPulmonology
Modalities
Cell therapyStem cell therapyAutologous cell therapyAllogeneic cell therapyDevice
Industry
Biotech
02

Partnerships

Zimmer BiometMaryland Stem Cell Research FundCenters for Medicare and Medicaid Services

Beyond the preview

Go deeper on CardiAMP.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Full profile access

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Full profile access

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Full profile access

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Full profile access

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Full profile access

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on CardiAMP.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call